30 African startups selected to be supported

The pan-African “Investing in Innovation” program, funded by the Bill & Melinda Gates Foundation and sponsored by Merck Sharp & Dohme (MSD), the World Health Organization’s Regional Office for Africa and AmerisourceBergen, aims to invest in the most promising African startups in the start-up phase or affects the supply chain of healthcare products. This program has just selected 30 startups in 14 African countries.

Investing in Innovation (i3), a pan-African initiative supporting emerging healthcare supply chains in Africa, has announced its first cohort of 30 startups.

Funded by the Bill & Melinda Gates Foundation and sponsored by Merck Sharp & Dohme (MSD), the World Health Organization’s Regional Office for Africa and AmerisourceBergen, i3 brings together major donors, industry leaders and African institutions to initiate a new approach to business support health innovations made by Africans.

A grant of $50,000

Selected startups will receive a $50,000 grant and support to catalyze growth-oriented partnerships with donors, industry leaders and institutions.

The 30 selected startups come from 14 African countries. These companies, which are in the start-up or growth phase, offer innovative solutions, especially for distribution of drugs and medical devices, management and financing of warehouses, authentication, traceability and management of medical waste. They demonstrate that Made in Africa solutions are poised to help transform access to healthcare products in many ways. 47% of companies are led by women (which the program defines as having at least one woman with a shareholding and an active leadership role), and 30% of companies operate in Francophone Africa.

They chose startups

Startups selected by region

The selected startups are: Aviro Health (South Africa), Contro (South Africa), Zinacare (South Africa), Appy Saude (Angola), Infiuss Health limited (Cameroon), Valorigo (Congo), Meditect (Côte d’Ivoire), Erith Health Services (Ghana), Damu Sasa (Kenya), The Pathology Network (Kenya), Negus Med (Kenya), Zuri Health (Kenya) Xetova (Kenya), DeepEcho (Morocco), Medevice (Morocco), Sobrus (Morocco), Chekkit Technologies (Nigeria), Disrupt Pharma Tech Africa – Medsaf (Nigeria), DrugStoc Ehub Limited (Nigeria), Gricd (Nigeria), LifeBank (Nigeria), Lifestores Healthcare (Nigeria), OneHealth (Nigeria),

ClinicPesa (Uganda), Signalytic (Uganda), Viebeg Technologies (Rwanda), Dr Sett (Senegal), Cure Bionics (Tunisia), VaxiGlobal (Zimbabwe), Azanza Health (Zimbabwe).

i3 is coordinated by Salient Advisory, SCIDaR and SouthBridge A&I and implemented by the main technology centers on the continent: CcHUB for West Africa, Startupbootcamp Afritech for Southern Africa, IMPACT Lab for North Africa and Francophone, and Villgro Africa for East Africa.

These hubs are responsible for the selection process and monitoring of startups throughout the program.

Ann AllenSenior Program Officer at the Bill & Melinda Gates Foundation, comments: “Digitally enabled, locally led innovations have enormous potential to help address the challenges of access to medicines for historically underserved patients in Africa. We are pleased to see women leaders in at the forefront of many of these start-ups, because we know that innovation ecosystems are strengthened by diversity. »

Dr. Abdullahi Sheriff, Associate Vice President of Global Market Access at MSD, noted, “The innovation represented by the selected start-ups is inspiring. At MSD, we are excited about the opportunity to partner with these leading innovators through i3 to help transform healthcare supply chains and improve access to medicines across Africa”

Efosa Ojomo, Director of Global Prosperity at the Clayton Christensen Institute and member of the i3 Steering Committee also commented: “i3’s focus on African ingenuity is long overdue – supporting local innovations, scalers will enable the continent to achieve health gains, create prosperity and overcome future crises. »

Prashant Yadav, Senior Fellow at the Center for Global Development and Professor at INSEAD, Chairman of the i3 Steering Committee, also commented

“The breadth of innovation represented by the cohort of selected companies confirms that data-driven innovations can play an important role in rapidly improving the resilience of healthcare supply chains in Africa.”

Leave a Comment